Table 1 of
Martin, Mol Vis 1999;
5:36.Table 1 of
Martin, Mol Vis 1999;
5:36.
Table 1. HSV-1 Shedding after Administration of Lysophosphatidic Acid (LPA) or Lysophosphatidylserine (LPS) by Three Methods
Frequency
-------------------------------------------- Average
Eyes Swabs Duration
-------------------- --------------------- Shedding**
Treatment +/Total % p* +/Total % p* (Days)
-------------------- ------- -- ----- ------- -- ------ ----------
Iontophoresis, LPA 6/8 75 - 18/56 32 - 2.25
Iontophoresis, LPS 3/8 37 0.315 6/56 11 <0.010 0.75
Collagen shield, LPA 3/8 37 - 6/56 11 - 0.75
Collagen shield, LPS 2/8 25 1.000 3/56 5 0.489 0.38
Topical drops, LPA 2/8 25 - 4/56 7 - 0.50
Topical drops, LPS 1/8 13 1.000 2/56 4 0.679 0.25
*P values obtained by two-tailed Fisher's exact test. Comparisons are between LPA
and LPS administration by each method.
**Total number of positive swabs per total number of eyes
|